Shipei Qiu

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Second Affiliated Hospital of Nanjing Medical University(Current)

Shipei Qiu is an author at Second Affiliated Hospital of Nanjing Medical University specializing in oncology, molecular biology, and cancer cell signaling.

Publications per year

2021–2022

Publications

RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1α–XBP1s pathway

Li Ma, Xiaojun Yang, Hao Peng et al. · Cell Death Discovery · 2021 · 51 citations · Full text

Medicine, Molecular Biology, Oncology +15

TSPAN31 regulates the proliferation, migration, and apoptosis of gastric cancer cells through the METTL1/CCT2 pathway

Xiang Ma, Shipei Qiu, Xin Tang et al. · Translational Oncology · 2022 · 22 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

1–2 of 2